(CercleFinance.com) – The Paris Stock Exchange should open sharply higher in view of futures on the CAC40, up by around 0.6% towards 6,545 points, in volumes probably tenuous with the absence of certain investors in this week of truce for confectioners.
Confidence could be boosted by Friday’s positive close on Wall Street (+0.5% on the Dow Jones, +0.2% on the Nasdaq), as traders seem to have rather appreciated the overall picture drawn by the series of American statistics. of the session.
Indeed, mixed activity data pleaded for a less restrictive attitude from the Fed: while sales of new homes increased by 5.8% in November, orders for durable goods contracted by 2.1% on the same period.
“We doubt that the rise in new home sales marks the start of a recovery and we still expect 2023 to be a weak year for sales,” Capital Economics said after this publication.
Hopes for a less tight monetary policy in the coming months were also fueled by a ‘core PCE’ price index (excluding food and energy), closely followed by the Federal Reserve, which only rose by 4 .7% in November, against 5.5% the previous month.
On the securities front in Paris, Ipsen said on Friday evening that it had received a full response letter from the FDA on its request for approval of palovarotene, an experimental treatment for fibrodysplasia ossificans progressiva.
Bic announced the finalization of its share buyback program with an ESG component, announced and started in January 2022, a program carried out by BNP Paribas Exane on the basis of the authorization granted by the general meeting of May 19, 2021.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
